These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8167117)

  • 1. What are the implications of cardiac infection with cytomegalovirus before heart transplantation?
    Lowry RW; Adam E; Hu C; Kleiman NS; Cocanougher B; Windsor N; Bitar JN; Melnick JL; Young JB
    J Heart Lung Transplant; 1994; 13(1 Pt 1):122-8. PubMed ID: 8167117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
    Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
    J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients.
    Lam KM; Oldenburg N; Khan MA; Gaylore V; Mikhail GW; Strouhal PD; Middeldorp JM; Banner N; Yacoub M
    J Heart Lung Transplant; 1998 Jun; 17(6):555-65. PubMed ID: 9662090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic and molecular diagnosis of myocardial human cytomegalovirus infection after heart transplantation.
    Pucci A; Ghisetti V; Donegani E; Barbui A; David E; Fortunato M; Papandrea C; Pansini S; Zattera G; di Summa M
    J Heart Lung Transplant; 1994; 13(6):1072-80. PubMed ID: 7865514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of DNA of cytomegalovirus, its antibodies and viral antigens in patients after organ transplantation].
    Dolgikh MS; Vediakov AM; Feoktistova EIu; Adueva SM; Makarova NE; Kushch AA; Pustovoĭt B
    Biull Eksp Biol Med; 1999 May; 127(5):560-3. PubMed ID: 10399583
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytomegalovirus detection in lung transplant biopsy samples by polymerase chain reaction.
    Flint A; Frank TS
    J Heart Lung Transplant; 1994; 13(1 Pt 1):38-42. PubMed ID: 8167125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic and molecular profile of human cytomegalovirus infections in patients with heart transplants.
    Arbustini E; Grasso M; Diegoli M; Percivalle E; Grossi P; Bramerio M; Campana C; Goggi C; Gavazzi A; Vigano M
    Am J Clin Pathol; 1992 Aug; 98(2):205-13. PubMed ID: 1324600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited cytomegalovirus-specific immunoglobulin M and immunoglobulin G profiles in heart transplant recipients.
    Allen MD; Denny CF; Kruse AP; Revkin JH; Fishbein DP; Ashley RL
    J Heart Lung Transplant; 1991; 10(5 Pt 1):664-73. PubMed ID: 1659902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical course of cytomegalovirus infection in renal transplant recipients].
    Luchsinger V; Suárez M; Montiel F; Kaltwasser G
    Rev Med Chil; 1999 Jan; 127(1):9-17. PubMed ID: 10436673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
    Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
    Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus and acute rejection after heart transplantation are not directly associated.
    Boriskin YS; Booth JC; Corbishley CM; Madden BP; McKenna WJ; Murday AJ; Steel HM
    J Med Virol; 1996 Sep; 50(1):59-70. PubMed ID: 8890042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
    George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
    J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spectrum of cytomegalovirus infection following human heart-lung transplantation.
    Burke CM; Glanville AR; Macoviak JA; O'Connell BM; Tazelaar HD; Baldwin JC; Jamieson SW; Theodore J
    J Heart Transplant; 1986; 5(4):267-72. PubMed ID: 3040942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?
    Osman HK; Peiris JS; Taylor CE; Warwicker P; Jarrett RF; Madeley CR
    J Med Virol; 1996 Apr; 48(4):295-301. PubMed ID: 8699160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation.
    Peggs KS; Preiser W; Kottaridis PD; McKeag N; Brink NS; Tedder RS; Goldstone AH; Linch DC; Mackinnon S
    Br J Haematol; 2000 Dec; 111(3):782-90. PubMed ID: 11122138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of cytomegalovirus infection-associated histologic findings in endomyocardial biopsies of heart allografts.
    Koskinen PK; Krogerus LA; Nieminen MS; Mattila SP; Häyry PJ; Lautenschlager IT
    J Heart Lung Transplant; 1993; 12(3):343-54. PubMed ID: 8392371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
    Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation.
    Sarmiento E; Rodríguez-Molina J; Muñoz P; Fernández-Yánez J; Palomo J; Fogueda M; Fernández-Cruz E; Bouza E; Carbone J
    Transplant Proc; 2005 Nov; 37(9):4046-9. PubMed ID: 16386623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.